Atul Dandekar SEC EDGAR Filings (CIK 0002050167)

SEC EDGAR filings, ownership reports, and insider transactions for Atul Dandekar.

Business address
C/O Maze Therapeutics, Inc., 171 Oyster Point Boulevard, Suite 300, South San Francisco, CA, 94080
Top holdings (ownership)
MAZE
Get insider transactions for this reporting owner
Atul Dandekar has filed 5 SEC EDGAR filings since 30 Jan 2025

Latest Filings

Recent SEC filings for Atul Dandekar including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 02 Feb 2026 29 Jan 2026 001-42490
4 Open 4 document View SEC filing for 4 31 Dec 2025 29 Dec 2025 001-42490
144 Open 144 document View SEC filing for 144 29 Dec 2025
4 Open 4 document View SEC filing for 4 24 Sep 2025 22 Sep 2025 001-42490
3 Open 3 document View SEC filing for 3 30 Jan 2025 30 Jan 2025 001-42490

About this filer

Atul Dandekar files with the SEC under CIK 0002050167. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages